Premium
Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy
Author(s) -
Chow Victor A.,
Gopal Ajay K.,
Maloney David G.,
Turtle Cameron J.,
Smith Stephen D.,
Ujjani Chaitra S.,
Shadman Mazyar,
Cassaday Ryan D.,
Till Brian G.,
Tseng Yolanda D.,
Warren Edus H.,
Shustov Andrei R.,
Me Manoj P.,
Bhark Sandra,
Acharya Utkarsh H.,
Mullane Erin,
Hannan Lindsay M.,
Voutsinas Jenna M.,
Gooley Ted A.,
Lynch Ryan C.
Publication year - 2019
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25505
Subject(s) - medicine , oncology , chimeric antigen receptor , chemoimmunotherapy , salvage therapy , lymphoma , population , diffuse large b cell lymphoma , clinical trial , immunology , cancer , rituximab , immunotherapy , chemotherapy , environmental health
REFERENCES 1. Taher AT, Cappellini MD, Bou-Fakhredin R, Coriu D, Musallam KM. Hypercoagulability and vascular disease. Hematol Oncol Clin North Am. 2018;32:237-245. 2. Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018; 391:155-167. 3. Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA. Non-transfusion-dependent thalassemias. Haematologica. 2013;98:833-844. 4. Taher AT, Musallam KM, Saliba AN, Graziadei G, Cappellini MD. Hemoglobin level and morbidity in non-transfusion-dependent thalassemia. Blood Cells Mol Dis. 2015;55:108-109. 5. Taher AT, Musallam KM, Karimi M, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010; 115:1886-1892. 6. Taher AT, Musallam KM, Karimi M, et al. Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost. 2010;8:2152-2158. 7. Musallam KM, Cappellini MD, Daar S, et al. Serum ferritin level and morbidity risk in transfusion-independent patients with beta-thalassemia intermedia: the ORIENT study. Haematologica. 2014;99:e218-e221. 8. Taher AT, Musallam KM, El-Beshlawy A, et al. Age-related complications in treatment-naive patients with thalassaemia intermedia. Br J Haematol. 2010;150:486-489. 9. Taher AT, Cappellini MD. How I manage medical complications of beta-thalassemia in adults. Blood. 2018;132:1781-1791.